Lano Blocking Peptide

Cat# L177-50

Size : 50ug

Brand : Leinco Technologies


Lano Blocking Peptide

Product No.: L177

[product_table name="All Top" skus="L177"]

Target
Lano
Product Type
Blocking Peptide
Alternate Names
LRRC1

Antibody Details

Product Details

Reactive Species
Human
Product Concentration
0.2 mg/ml
Amino Acid Location
15 amino acids near the carboxy terminus of human Lano.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at 20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Amino Acid Sequence
15 amino acids near the carboxy terminus of human Lano.
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.

Description

Background
Lano peptide is applicable as a control peptide for blocking antibody binding in Western blotting.

References & Citations

1. Dumoutier L, Louahed J, Renauld JC. Cloning and characterization of IL10related T cellderived inducible factor (ILTIF), a novel cytokine structurally related to IL10 and inducible by IL9. J Immunol. 2000;164(4):18149. 2. Dumoutier L, Van Roost E, Colau D, Renauld JC. Human interleukin10related T cellderived inducible factor: molecular cloning and functional characterization as an hepatocytestimulating factor. Proc Natl Acad Sci USA . 2000 ;97(18):101449. 3. Xie MH, Aggarwal S, Ho WH, et al. Interleukin (IL)22, a novel human cytokine that signals through the interferon receptorrelated proteins CRF24 and IL22R. J Biol Chem. 2000;275(40):313359. 4. Kotenko SV, Izotova LS, Mirochnitchenko OV, et al. Identification of the functional interleukin22 (IL22) receptor complex: J Biol Chem. 2001;276(4):272532.
Prod No.
Description
L172
L177
Disclaimer AlertProducts are for research use only. Not for use in diagnostic or therapeutic procedures.
Page load link
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy. Ok